Search Results - "Nicolini, S"

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors by Bodei, L., Kidd, M., Modlin, I. M., Severi, S., Drozdov, I., Nicolini, S., Kwekkeboom, D. J., Krenning, E. P., Baum, R. P., Paganelli, G.

“…Background Peptide receptor radionuclide therapy (PRRT) is an effective method for treating neuroendocrine tumors (NETs). It is limited, however, in the…”
Get full text

Inert gas narcosis in scuba diving, different gases different reactions by Rocco, Monica, Pelaia, P., Di Benedetto, P., Conte, G., Maggi, L., Fiorelli, S., Mercieri, M., Balestra, C., De Blasi, R. A.

“…Purpose Underwater divers face several potential neurological hazards when breathing compressed gas mixtures including nitrogen narcosis which can impact…”
Get full text

Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials by Severi, S., Bongiovanni, A., Ferrara, M., Nicolini, S., Di Mauro, F., Sansovini, M., Lolli, I., Tardelli, E., Cittanti, C., Di Iorio, V., Mezzenga, E., Scarpi, E., Ibrahim, T., Paganelli, G., Zovato, S.

“…Pheochromocytoma and paraganglioma (PPGL) have currently only limited treatment options available for patients in the metastatic phase (mPPGL) in either…”
Get full text

Non FDG PET by Nanni, C, Fantini, L, Nicolini, S, Fanti, S

“…2- [18 F]-fluoro-2-deoxy- d- glucose (FDG) is the radiopharmaceutical most frequently used for clinical positron emission tomography (PET). However, FDG cannot…”
Get full text

1826P Lutetium-177-PSMA in pre- and post-taxane mCRPC setting: Results from a phase II clinical trial by Giunta, E.F., Sansovini, M., Grassi, I., Marini, I., Brighi, N., Lolli, C., Schepisi, G., Nicolini, S., Foca, F., Monti, M., Celli, M., Caroli, P., Di Iorio, V., Sarnelli, A., Severi, S., Paganelli, G., Matteucci, F., De Giorgi, U.F.F.

Get full text

1103P 177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase II prospective clinical trials by Bongiovanni, A., Nicolini, S., Foca, F., Sansovini, M., Grassi, I., Liverani, C., Riva, N., Fausti, V., Mercatali, L., De Vita, A., Fabbri, L., Signoretti, M., Pacilio, C.A., Paganelli, G., Severi, S., Ibrahim, T., Tartaglia, A.

Get full text

Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients by Celli, M, De Giorgi, U, Caroli, P, Di Iorio, V, Fantini, L, Rossetti, V, Foca, F, Nicolini, S, Giganti, M, Paganelli, G, Matteucci, F

“…Purpose To evaluate the clinical value of 68 Ga-PSMA PET/CT negativity in patients with biochemical recurrent prostate cancer (BCR). Methods One hundred three…”
Get full text

Targeted alpha PSMA-based therapy of metastatic castrate-resistant prostate-cancer patients (mCRPC): prediction dosimetry by Belli, M.L., Mezzenga, E., Cesarini, F., Caroli, P., Di Iorio, V., Cremonesi, M., Strigari, L., Romeo, A., Nicolini, S., Matteucci, F., Severi, S., Paganelli, G., Sarnelli, A.

Get full text

OD71 - Targeted alpha PSMA-based therapy of metastatic castrate-resistant prostate-cancer patients (mCRPC): prediction dosimetry by Belli, M.L., Mezzenga, E., Cesarini, F., Caroli, P., Di Iorio, V., Cremonesi, M., Strigari, L., Romeo, A., Nicolini, S., Matteucci, F., Severi, S., Paganelli, G., Sarnelli, A.

Get full text

OL47 - Targeted alpha PSMA-based therapy of metastatic castrate-resistant prostate-cancer patients (mCRPC): prediction dosimetry by Belli, M.L., Mezzenga, E., Cesarini, F., Caroli, P., Di Iorio, V., Cremonesi, M., Strigari, L., Romeo, A., Nicolini, S., Matteucci, F., Severi, S., Paganelli, G., Sarnelli, A.

Get full text

Targeted alpha PSMA-based therapy of metastatic castrate-resistant prostate-cancer patients (mCRPC): prediction dosimetry by Belli, M.L., Mezzenga, E., Cesarini, F., Caroli, P., Di Iorio, V., Cremonesi, M., Strigari, L., Romeo, A., Nicolini, S., Matteucci, F., Severi, S., Paganelli, G., Sarnelli, A.

Get full text

Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick by Tarugi, P, Nicolini, S, Marchi, L, Ballarini, G, Calandra, S

“…In the chick, the large cholesteryl ester (CE) store present in the liver during the last period of embryonic life increases at hatching and is rapidly…”
Get full text

Therapy with 177Lu-PSMA-617 in advanced mCRPC patients: Results of the phase 2 prospective trial IRST-185.03 (EUDRACT: 2016-002732-32) by Marini, I., Sansovini, M., Paganelli, G., Grassi, I., Matteucci, F., Nicolini, S., De Giorgi, U., Giunta, E.F., Foca, F., Monti, M., Celli, M., Caroli, P., Di Iorio, V., Sarnelli, A., Lolli, C., Schepisi, G., Brighi, N., Severi, S.

Get full text

UP43 - Therapy with 177Lu-PSMA-617 in advanced mCRPC patients: Results of the phase 2 prospective trial IRST-185.03 (EUDRACT: 2016-002732-32) by Marini, I., Sansovini, M., Paganelli, G., Grassi, I., Matteucci, F., Nicolini, S., De Giorgi, U., Giunta, E.F., Foca, F., Monti, M., Celli, M., Caroli, P., Di Iorio, V., Sarnelli, A., Lolli, C., Schepisi, G., Brighi, N., Severi, S.

Get full text

Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer ( ROC) patients with BRCA 1/2 mutation. A monoistitutional experience by Scandurra, G., Marletta, F., Nicolini, S., Banna, G.L., Di Stefano, A.B., Cali', S., Acquaviva, G., Tamburo, M., Corsaro, G., Scibilia, G., Ippolito, M., Scollo, P.

Get full text

Correction to: Inert gas narcosis in scuba diving, different gases different reactions by Rocco, Monica, Pelaia, P., Di Benedetto, P., Conte, G., Maggi, L., Fiorelli, S., Mercieri, M., Balestra, C., De Blasi, R. A.

“…The original version of this article unfortunately contained a mistake…”
Get full text

Absence of apolipoprotein B-48 in the chick, Gallus domesticus by Tarugi, P, Albertazzi, L, Nicolini, S, Calandra, S

“…This study was designed to investigate: a) whether multiple forms of apoB are present in chick plasma lipoproteins; and b) which forms of apoB are produced in…”
Get full text

Clinical value of negative 68 Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients by Celli, M, De Giorgi, U, Caroli, P, Di Iorio, V, Fantini, L, Rossetti, V, Foca, F, Nicolini, S, Giganti, M, Paganelli, G, Matteucci, F

“…To evaluate the clinical value of Ga-PSMA PET/CT negativity in patients with biochemical recurrent prostate cancer (BCR). One hundred three BCR patients…”
Get full text

Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver by Tarugi, P, Nicolini, S, Ballarini, G, Marchi, L, Duvigneau, C, Tartoni, P, Calandra, S

“…We investigated in the chick whether the diet-induced changes of the hepatic content of cholesteryl esters (CE) influence the synthesis and the secretion of…”
Get full text

Synthesis and secretion of apolipoprotein A-I by chick skin by Tarugi, P, Albertazzi, L, Nicolini, S, Ottaviani, E, Calandra, S

“…Chick skin slices were incubated with [35S]methionine and labeled apoA-I was immunoprecipitated from incubation medium and tissue homogenate. ApoA-I accounted…”
Get full text